---
title: "Apollo Hospitals Enterprise Ltd (APOLLOHOSP) — Share Price, Financials & Analysis"
symbol: "APOLLOHOSP"
company: "Apollo Hospitals Enterprise Ltd"
canonical: "https://tapetide.com/stocks/APOLLOHOSP"
isin: "INE437A01024"
nse_symbol: "APOLLOHOSP"
bse_code: "508869"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 126882.77
generated_at: "2026-09-13T19:17:10.215Z"
---

# Apollo Hospitals Enterprise Ltd (APOLLOHOSP)

Canonical page: https://tapetide.com/stocks/APOLLOHOSP

## Company

- **NSE Symbol:** APOLLOHOSP
- **BSE Code:** 508869
- **ISIN:** INE437A01024
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1996-01-10
- **CEO:** Dr. Prathap Chandra Reddy FCCP, FICA, FRCS, M.D., MBBS
- **Employees:** 42497
- **Face Value:** ₹5
- **F&O Eligible:** Yes
- **Website:** apollohospitals.com

## About

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.
Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]

## Latest Price

- **Price:** ₹8836
- **Change:** -64 (-0.72%)
- **Open:** ₹8806
- **Day High:** ₹8950
- **Day Low:** ₹8806
- **Previous Close:** ₹8900
- **Volume:** 207930
- **As Of:** 2026-09-11T10:22:31+00:00

## Key Fundamentals

Observed at 2026-09-11T04:33:55.139527Z.

- **Market Cap:** ₹126882.77 Cr
- **Classification:** Largecap
- **P/E (reported):** 58.8
- **P/E (TTM):** 60.8
- **EPS (TTM):** ₹145.32
- **EPS (reported):** ₹72.05
- **Book Value:** ₹659.33
- **Price to Book:** 13.46
- **Dividend Yield:** 0.22%
- **ROE:** 20.08%
- **ROCE:** 19.79%
- **Debt to Equity:** 0.9
- **Revenue (yearly):** ₹25420.1 Cr
- **Net Income:** ₹2002.7 Cr
- **EBITDA:** ₹3960.9 Cr
- **52-Week High:** ₹9050
- **52-Week Low:** ₹6696.5
- **RSI (14):** 54.83

## Tapetide Score

- **Score:** 41 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 17.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 25.64 | 9% |
| growth | 48.06 | 9% |
| momentum | 32.04 | 12% |
| ownership | 46.3 | 24% |
| quality | 45.55 | 22% |
| valuation | 36.95 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 76.2% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 17.7%

### Weaknesses

- Stock is trading at 13.4 times its book value
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 33.67% | 48.72% | 68.38% |
| ebitda margin growth | 8.38% | 6.35% | 19.57% | 1.5% |
| net income growth | 10.72% | 33.06% | 32% | 76% |
| revenue growth | 6.7% | 15.58% | 15% | 19% |
| roce | 9.35% | 27.43% | 30.71% | 16.45% |
| roe | 10.72% | 15.47% | 16.75% | 7.67% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4847 | 4851 | 4944 | 5086 | 5589 | 5527 | 5592 | 5842 | 6304 | 6477 | 6606 | 7044 |
| Expenses | 4219 | 4237 | 4303 | 4410 | 4774 | 4765 | 4822 | 4990 | 5362 | 5512 | 5594 | 5951 |
| Operating Profit | 628 | 614 | 640 | 675 | 816 | 762 | 770 | 852 | 941 | 965 | 1011 | 1092 |
| OPM % | 13 | 13 | 13 | 13 | 15 | 14 | 14 | 15 | 15 | 15 | 15 | 16 |
| Other Income | 26 | 29 | 37 | 49 | 44 | 69 | 72 | 54 | 61 | 48 | 54 | 62 |
| Interest | 111 | 113 | 119 | 116 | 118 | 110 | 115 | 108 | 110 | 113 | 119 | 120 |
| Depreciation | 163 | 167 | 190 | 177 | 184 | 185 | 211 | 215 | 218 | 219 | 224 | 235 |
| Profit before tax | 379 | 363 | 368 | 430 | 557 | 536 | 516 | 583 | 675 | 682 | 722 | 799 |
| Tax % | 34 | 30 | 30 | 27 | 29 | 29 | 20 | 24 | 27 | 24 | 24 | 24 |
| Net Profit | 249 | 254 | 258 | 316 | 396 | 379 | 414 | 441 | 494 | 516 | 551 | 610 |
| EPS in Rs | 16.2 | 17.06 | 17.65 | 21.23 | 26.34 | 25.89 | 27.1 | 30.1 | 33.19 | 34.93 | 36.81 | 40.39 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 8243 | 9617 | 11247 | 10560 | 14663 | 16612 | 19059 | 21794 | 25228 | 26430 |
| Expenses | 7442 | 8548 | 9656 | 9420 | 12474 | 14548 | 16665 | 18761 | 21449 | 22420 |
| Operating Profit | 801 | 1070 | 1591 | 1140 | 2189 | 2065 | 2394 | 3033 | 3779 | 4010 |
| OPM % | 10 | 11 | 14 | 11 | 15 | 12 | 13 | 14 | 15 | 15 |
| Other Income | 24 | 26 | 222 | 103 | 368 | 75 | 123 | 222 | 207 | 226 |
| Interest | 295 | 327 | 533 | 449 | 379 | 381 | 449 | 458 | 450 | 462 |
| Depreciation | 359 | 396 | 620 | 573 | 601 | 615 | 687 | 758 | 876 | 896 |
| Profit before tax | 171 | 373 | 660 | 221 | 1578 | 1144 | 1380 | 2039 | 2661 | 2877 |
| Tax % | 65 | 47 | 34 | 38 | 30 | 22 | 32 | 26 | 25 | — |
| Net Profit | 60 | 200 | 432 | 137 | 1108 | 844 | 935 | 1505 | 2003 | 2172 |
| EPS in Rs | 8.44 | 16.96 | 32.7 | 10.46 | 73.42 | 56.97 | 62.5 | 100.56 | 135.04 | 145.32 |
| Dividend Payout % | 59 | 35 | 18 | 29 | 16 | 26 | 26 | 13 | 15 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 70 | 70 | 70 | 70 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 3244 | 3182 | 3264 | 3270 | 4531 | 5551 | 6126 | 6864 | 8140 | 9408 |
| Borrowings | 3125 | 3427 | 3673 | 3596 | 4160 | 4068 | 4332 | 5333 | 7864 | 8493 |
| Other Liabilities | 1665 | 1917 | 2159 | 4354 | 2629 | 3570 | 3886 | 4474 | 4568 | 4210 |
| Total Liabilities | 8103 | 8596 | 9166 | 11289 | 11392 | 13261 | 14416 | 16742 | 20644 | 22183 |
| Fixed Assets | 4591 | 4773 | 4982 | 7432 | 6778 | 8296 | 8520 | 9664 | 10988 | 12272 |
| CWIP | 347 | 712 | 822 | 236 | 234 | 46 | 610 | 873 | 921 | 1032 |
| Investments | 406 | 352 | 462 | 434 | 1343 | 816 | 574 | 986 | 2487 | 2179 |
| Other Assets | 2759 | 2759 | 2901 | 3187 | 3037 | 4104 | 4712 | 5219 | 6248 | 6700 |
| Total Assets | 8103 | 8596 | 9166 | 11289 | 11392 | 13261 | 14416 | 16742 | 20644 | 22183 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 623 | 537 | 905 | 1293 | 1265 | 1696 | 1377 | 1920 | 2136 | 2856 |
| Cash from Investing Activity | -1152 | -405 | -711 | -289 | -880 | -747 | -857 | -1537 | -3383 | -2145 |
| Cash from Financing Activity | 477 | -108 | -215 | -910 | -340 | -792 | -633 | -311 | 1319 | -478 |
| Net Cash Flow | -52 | 24 | -20 | 94 | 44 | 158 | -113 | 72 | 73 | 233 |
| Free Cash Flow | -46 | -84 | 233 | 782 | 984 | 1044 | 252 | 785 | 439 | 925 |
| CFO/OP | 103 | 83 | 103 | 100 | 108 | 87 | 85 | 100 | 86 | 92 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 38 | 37 | 39 | 33 | 46 | 44 | 49 | 48 | 51 | 50 |
| Inventory Days | 47 | 51 | 46 | 49 | 16 | 21 | 17 | 17 | 16 | 15 |
| Days Payable | 51 | 55 | 56 | 60 | 74 | 79 | 82 | 88 | 72 | 63 |
| Cash Conversion Cycle | 34 | 33 | 29 | 22 | -12 | -14 | -16 | -23 | -6 | 3 |
| Working Capital Days | 27 | 8 | -3 | -8 | -4 | 5 | -1 | -19 | -6 | -25 |
| ROCE % | 8 | 7 | 10 | 14 | 8 | 17 | 14 | 15 | 17 | 17 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.33% | 29.34% | 29.34% | 28.02% | 28.02% | 28.02% | 28.02% |
| FIIs | 46.15% | 46.25% | 45.63% | 43.92% | 45.37% | 45.27% | 42.74% | 43.49% | 44.2% | 43.54% | 42.62% | 41.5% |
| DIIs | 18.6% | 17.97% | 19.55% | 21.14% | 19.95% | 19.98% | 22.29% | 21.34% | 21.12% | 21.51% | 22.76% | 23.72% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 4.04% | 3.7% | 3.74% | 3.81% | 3.62% | 3.65% | 3.81% | 3.98% | 4.44% | 4.7% | 4.39% | 4.48% |
| Others | 1.65% | 2.51% | 1.52% | 1.57% | 1.5% | 1.54% | 1.6% | 1.62% | 1.99% | 2.01% | 1.98% | 2.05% |
| No. of Shareholders | 131565 | 119578 | 130664 | 127754 | 119245 | 127802 | 134058 | 141007 | 160556 | 178648 | 174610 | 174281 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 11 / 7 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 8801.5 | Buy |
| EMA (10) | 8823.34 | Buy |
| SMA (20) | 8791.58 | Buy |
| EMA (20) | 8810.07 | Buy |
| SMA (50) | 8837.42 | Sell |
| EMA (50) | 8744.66 | Buy |
| SMA (100) | 8526.5 | Buy |
| EMA (100) | 8515.97 | Buy |
| SMA (200) | 7922.05 | Buy |
| EMA (200) | 8130.08 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 51.57 | Neutral |
| MACD (12,26,9) | 12.53 | Buy |
| Stochastic (14,3,3) | 73.47 | Neutral |
| ADX (14) | 15.54 | Neutral |
| Williams %R (14) | -48.96 | Neutral |
| ATR (14) | 148.01 | Neutral |
| ROC (12) | 0.79 | Buy |
| Stoch RSI (14) | 55.2 | Neutral |
| UO (7,14,28) | 48.43 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 23 | 85.19% |
| Hold | 3 | 11.11% |
| Sell | 1 | 3.7% |

Based on 27 analyst ratings, observed at 2026-09-11T04:33:55.239327+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Notice For Transfer Of Shares To IEPF](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fa81c73-efb4-4ed8-ae36-a8310a0ef5d2.pdf) |
| 2026-08-28 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df740957-5277-4434-9808-189da93447aa.pdf) |
| 2026-08-25 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2b510c6-b8c6-4929-96af-86df282a6d5e.pdf) |
| 2026-08-25 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e9f9591-d89b-4435-b22b-441648227e3e.pdf) |
| 2026-08-25 | [Summary Of Proceedings Of AGM And Voting Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cd78bd7-60df-449f-a4ee-6dfa89824152.pdf) |
| 2026-08-19 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca5fdfc6-1b00-4603-9386-00e04dff212f.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f95c0844-ab21-4e1f-9621-67d1f33aa051.pdf) |
| 2026-08-12 | [Board Meeting Outcome for Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c618c7b8-5380-425e-963f-1a6d26371e94.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a50e5850-8fbc-4ccd-abfa-0c7b2589ddbb.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a84c3404-a9a5-44cd-91cd-9f260152c1c1.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Outcome Of The Board Meeting - Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87b1d6b9-8b44-4920-a432-c721f2c2a442.pdf) |
| 2025-08-12 | [As Per Annexure Enclosed](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c141ce3-c2fd-4076-ad3c-945894ee9a3e.pdf) |
| 2025-05-30 | [Audited Financial Results For The Quarter And Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9eabea1d-0815-47bc-a93c-1cf2310483da.pdf) |
| 2025-02-10 | [Unaudited Financial Results For Three And Nine Months Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57df9bb9-13a1-4829-8212-ee29c8e78f8a.pdf) |
| 2024-11-06 | [Financial Results For The Three And Six Months Ended 30Th Sept 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ec481a3-aa65-4738-8ec1-3f32c4b5e565.pdf) |
| 2024-08-13 | [Financial Results For The Quarter Ended 30Th June 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff7272d9-0db3-4375-b3b8-b366e5c12a8a.pdf) |
| 2024-08-13 | [Outcome Of The Board Meeting (Revised) - Financial Results With Segment Report And Limited Review Report With UDIN](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7032671c-f9b9-4b34-a4a7-54673d2525a2.pdf) |
| 2024-05-30 | [Financial Results For The Quarter And Year Ended 31St March 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb047692-491e-48a6-b75e-8f0d601e3ed2.pdf) |
| 2024-02-08 | [Unaudited Financial Results For The Quarter And Nine Months Ended 31St Dec 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9d1a3a6-772d-4cc5-907a-f7fe8223c2cb.pdf) |
| 2023-11-09 | [Financial Results For The Quarter And Half Year Ended 30Th Sept 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f556f47-43c9-4d84-bab2-a78303da66bc.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a967b34-eaeb-44d0-82d8-5ff46e9b171f.pdf) |
| 2026-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cfb1747-054b-47c2-8073-a98cba8daca0.pdf) |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2256258c-6663-42bc-866c-402f5dcc1cae.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4430a828-14c2-4c64-8cff-b68f1a2904f1.pdf) |
| 2025-06-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f30907dc-d76c-4a3b-bbf9-7a8b5121223c.pdf) |
| 2025-05-31 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b850535c-b6c7-417c-9899-007a8bd0d2c8.pdf) |
| 2025-05-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14a059cf-24b8-4d1a-a641-c917bfff7dda.pdf) |
| 2025-02-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dce7bcc1-c27f-4f71-87bb-fd3e836c1c2e.pdf) |
| 2024-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c8e1593-fa2f-4a22-b0c9-c6c05d77e1f1.pdf) |
| 2024-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7080cbe6-f674-42ae-a86b-6ffb155e4b13.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/345f32bf-f84d-4f53-babb-300fd5eadfd6.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7cfb1747-054b-47c2-8073-a98cba8daca0.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/7cfb1747-054b-47c2-8073-a98cba8daca0.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14a059cf-24b8-4d1a-a641-c917bfff7dda.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b850535c-b6c7-417c-9899-007a8bd0d2c8.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b25a9ffe-b4a6-4942-8238-6d7d4f501f5d.pdf) |
| Jun 2021 | [Concall - Jun 2021](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c09a339-82bb-4ba3-b498-fde0e74c335d.pdf) |
| Jun 2021 | [Concall - Jun 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9c09a339-82bb-4ba3-b498-fde0e74c335d.pdf) |
| Jun 2021 | [Concall - Jun 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a6a64c84-3719-43d2-9ce5-3943605ff416.pdf) |
| Jun 2021 | [Concall - Jun 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/994f71ca-1de4-430a-ac6e-1e0d90516364.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8h - Apollo Hospitals received NCLT order dated 15 Apr 2026, modifying scheme-related meeting dates. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 8h - Apollo Hospitals received NCLT order dated 15 Apr 2026, modifying scheme-related meeting dates.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/795a3fc6-f16b-4267-ab77-75c6633b6f5c.pdf) |
| 8 May - NCLT allowed revised scheme meeting dates; unsecured creditors on 23-25 June 2026. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 8 May - NCLT allowed revised scheme meeting dates; unsecured creditors on 23-25 June 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1efe7d47-2e53-41fa-9496-932e4f2e6d32.pdf) |
| 7 Apr - Regulation 74(5) certificate filed for dematerialization details for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Regulation 74(5) certificate filed for dematerialization details for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d9acb15d-6370-40f6-aded-4e6eeda2fdfe.pdf) |
| 4 May - Board to approve FY26 audited standalone and consolidated results on May 20, 2026; final dividend may be recommended. | [Board Meeting Intimation for As Per Annexure Enclosed 4 May - Board to approve FY26 audited standalone and consolidated results on May 20, 2026; final dividend may be recommended.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dde7de6f-2ace-4afc-99e4-ed9fac31467d.pdf) |
| 4 May - Board to approve FY26 audited standalone and consolidated results on May 20, 2026; final dividend may be recommended. | [Board Meeting Intimation for As Per Annexure Enclosed 4 May - Board to approve FY26 audited standalone and consolidated results on May 20, 2026; final dividend may be recommended.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dde7de6f-2ace-4afc-99e4-ed9fac31467d.pdf) |
| 31 Mar - AHL acquired 100% of Apollo Consumer Products for INR 9.00 lakh; company incorporated March 11, 2026. | [Announcement under Regulation 30 (LODR)-Acquisition 31 Mar - AHL acquired 100% of Apollo Consumer Products for INR 9.00 lakh; company incorporated March 11, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9528374-4374-4088-9c4f-6fd4330deead.pdf) |
| 3 Apr - NCLT allowed Apollo Hospitals' composite scheme application on March 26, 2026; shareholder and creditor meetings ordered. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 3 Apr - NCLT allowed Apollo Hospitals' composite scheme application on March 26, 2026; shareholder and creditor meetings ordered.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1d9d2066-7a9b-48a5-9e81-00baf5b10fcf.pdf) |
| 29 Jan - Approved unaudited results for quarter ended 31 Dec 2025; accumulated losses ₹2,421.98L; auditor emphasis. | [Board Meeting Outcome for Outcome Of Board Meeting 29 Jan - Approved unaudited results for quarter ended 31 Dec 2025; accumulated losses ₹2,421.98L; auditor emphasis.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/caa7765a-2974-42e5-b6e6-333cf1bc2186.pdf) |
| 29 Jan - Approved Q3 results (Dec 31, 2025); accumulated loss ₹2,421.98L; discontinued spinning; assets held for sale ₹224.22L. | [Financial Results For The Quarter Ended 31.12.2025. 29 Jan - Approved Q3 results (Dec 31, 2025); accumulated loss ₹2,421.98L; discontinued spinning; assets held for sale ₹224.22L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7c21c389-2540-472b-b83c-a09b934cb5a5.pdf) |
| 27 Apr - Apollo Hospitals received NCLT order dated 15 Apr 2026, modifying scheme-related meeting dates. | [Announcement under Regulation 30 (LODR)-Scheme of Arrangement 27 Apr - Apollo Hospitals received NCLT order dated 15 Apr 2026, modifying scheme-related meeting dates.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/795a3fc6-f16b-4267-ab77-75c6633b6f5c.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9b40997-8116-48ba-949a-ca2e7775e3c2.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/330724b4-fb72-4577-beb0-598b4672f77a.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/61bacc26-184d-4540-865c-9045e8604ae6.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/93fc23fd-104c-47e7-bfc9-cf91d3d41e33.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9aabd30d-838f-4cf6-84fd-913d8fc47678.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/30d2900c-1d8f-4110-abf9-5e477e6ace9e.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6922f6c5-090b-4728-8f4d-f10406cfa1e6.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/508869/74069508869.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/514140/76584514140.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2022-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbe8d031-0a7e-4336-802c-5a5f8e2147f9.pdf) |
| 2022-08-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=346213db-e91d-4e28-8679-94c4edab53d0.pdf) |
| 2022-05-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d0f1bd59-45ca-43a9-ab65-f32edafe4b78.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:17:10.215Z.